ロード中...
Treatment with sorafenib and sunitinib in renal cell cancer: a Swedish register-based study
Sorafenib and sunitinib are used for renal cell carcinoma (RCC). The objective was to study the treatment duration and time to death in Swedish RCC patients on sorafenib or sunitinib as first-line or monotherapy or as sequential therapy. Patients with an RCC diagnosis were identified in the Swedish...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3586400/ https://ncbi.nlm.nih.gov/pubmed/23254966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-012-0331-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|